中国癌症杂志 ›› 2019, Vol. 29 ›› Issue (1): 71-80.doi: 10.19401/j.cnki.1007-3639.2019.01.011

• 指南与共识 • 上一篇    

驱动基因阳性非小细胞肺癌脑转移诊治上海专家共识(2019年版)

梁晓华,黄若凡,詹 琼   

  1. 复旦大学附属华山医院肿瘤科,上海 200040
  • 出版日期:2019-01-30 发布日期:2019-02-01
  • 通信作者: 梁晓华 E-mail:liangxiaohua@csco.ac.cn
  • 基金资助:
    上海市卫生计生委协同创新集群项目(2019CXJQ03)。

Shanghai expert consensus on the management of brain metastasis of non-small cell lung cancer with driver gene mutations

LIANG Xiaohua, HUANG Ruofan, ZHAN Qiong   

  1. Department of Oncology, Huashan Hospital, Fudan University, Shanghai 200040, China
  • Published:2019-01-30 Online:2019-02-01
  • Contact: LIANG Xiaohua E-mail: liangxiaohua@csco.ac.cn

摘要: 驱动基因阳性非小细胞肺癌(non-small cell lung cancer,NSCLC)脑转移是临床关注的热点,综合治疗是原则,不同治疗手段的合理组合和顺序安排,对延长患者生存期和提高生活质量有着重要意义。上海市抗癌协会脑转移瘤专业委员会组织专家制订了本共识,以规范驱动基因阳性NSCLC脑转移的诊治。

关键词: 非小细胞肺癌, 驱动基因突变, 靶向治疗, 放射治疗

Abstract: Brain metastasis of non-small cell lung cancer (NSCLC) with driver gene mutation is becoming a clinical highlight. Rational combination and sequencing of different treatment methods are of great significance for prolonging the survival time and improving the quality of life of patients. Experts from the Committee of Brain Metastases, Shanghai Anti-Cancer Association have formulated this consensus to standardize the diagnosis and treatment of brain metastasis from NSCLC with driver gene mutation.

Key words: Non-small cell lung cancer, Driver gene mutation, Targeted therapy, Radiotherapy